Plenary Speakers:
- Dr Cathal O’Reilly, Managing Director, Centreview Partners, London, United Kingdom
- “Australia in the global pharma and biopharma context”
- Willard H. Dere, M.D., Senior Vice President, International Chief Medical Officer, Amgen, United States
- “Biotechnology Industry Faces an Explosion of Scientific Advancements and a Tsunami of Real World Challenges”.
- Professor Ross McKinnon, Research Director and Professor in Cancer Research, Flinders Centre for Innovation in Cancer, School of Medicine, Flinders University
- "Translating health discovery into clinical applications: an Australian perspective"
Session Speakers*:
- Dr Jonathan Arthur, General Manager, CellBank Australia, Australia
- Mark Ashton, Manager Innovation and Commercial Development, UniQuest, Australia
- Geoff Bell, Chief Executive Officer, Microbiogen Australia
- Doron Ben-Meir, Chief Executive Officer, Commercialisation Australia, Australia
- Hershel Berry, Managing Partner, Blueprint Life Sciences, United States
- Warren Bingham, President - Australia & NZ, Given Imaging, Australia
- David Blake, Co-Founder, Bioshares, Australia
- Eric Boone, Partner, Baker & McKenzie, Australia
- Dr Ben Borson, Attorney, Borson Law Group, United States
- Dr Arthur Brandwood, Founder & CEO, Brandwood Biomedical, Australia
- James Brennan, Business Development Manager, Design + Industry, Australia
- Paul Brennan, Marketing Director ANZ Healthcare Division, Smith & Nephew Pty Ltd Australia
- Adj Professor Don Bursill AM, Chief Scientist of South Australia, Australia
- Matthew Callahan, Chief Executive Officer, iCeutica Inc, Australia
- Peter Chesworth, General Manager, Department of Innovation, Canberra, ACT
- Dr John Chiplin, Managing Director, Newstar Ventures, Australia
- Samantha Cobb, Chief Executive Officer, AdAlta, Australia
- Dr Greg Collier, Managing Director, Barwon Biotechnology, Australia
- Dr Anne Collins, Associate Director One 2 One Biosciences, Hospira Adelaide, Australia
- Dr Justin Coombs, Head of Agriculture, TPI Enterprises, Australia
- Ned Coten, Managing Director, Acorn Brand Design, Australia
- Dr Rob Crombie, Managing Director, Concept2Clinic Consulting, Australia
- Glenn Cross, Chief Operating Officer, AusBiotech, Australia
- Dr Rosalie Cull, Managing Director, TudorRose Consulting, Australia
- Dr Geoff Cumming, Chief Executive Officer, Anteo Diagnostics, Australia
- Professor Rocky De Nys, School of Marine and Tropical Biology, James Cook University, Australia
- Simon De Young, Partner, Baker & McKenzie, Australia
- Dr Janette Dixon, Vice President Global Business Development, QRx Pharma
- Trent Donnelly, Director Corporate Finance, E.L & C. Baillieu Stockbroking Australia
- Dr Ian Dry, Principal Research Scientist, CSIRO Plant Industry Division, Australia
- Dr Leigh Farrell, VP Business Development, Biota Holdings Limited, Australia
- Dr David Fisher, Partner, Brandon Capital, Australia
- Dr Peter French, CEO, Benitec Limited, Australia
- Dr David Fuller, Chief Operating Officer / Chief Medical Officer, INC Research, Australia
- Clarke Futch, Managing Director, Cowen Healthcare Royalty Partners, United States
- Dr Joshua Funder, Partner, GBS Venture Partners, Australia
- Robert Gay, Director Manufacturing, Cephalon Australia Pty Ltd
- Dr Harvey Glick, Senior Director, Scientific Affairs Asia, Monsanto, Singapore
- Marc Goemans, Senior Director New Business Development Asia – Pacific, DSM Biologics, Netherlands
- Lawrence Gozlan, Chief Executive Officer, Scientia Capital, Australia
- Hans-Peter Grau, Vice President Business Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
- Dr Simon Green, Senior Vice President Global Product Development, CSL Limited, Australia
- A/Professor John Greenwood, Director Burns Unit, The Royal Adelaide Hospital, Australia
- Associate Professor Ben Hankamer, Institute for Molecular Bioscience, University of Queensland, Australia
- David Harrison, General Manager, Brandwood Biomedical, Australia
- Dr Jenny Harry, CHief Executive Officer and Managing Director,Tyrian Diagnostics, Australia
- Dr Mark Harvey, Partner, CM Capital, Australia
- Dr Suzanne Hasthorpe, Manager, Coordinating Office for Human Research Ethics , Department of Health, Victoria , Australia
- Dr Robyn Heath, Senior VP Product Development, Hexima Limited, Australia
- Dr Mike Hirshorn, Director, Four Hats Capital, Australia
- T. Justus Homberg, Founder and Executive Director, YHI Ventures, Australia
- David Hughes, Chief Executive Officer, Biopharmaceuticals Australia, Australia
- Terry Hurst, Qpharm, Australia
- Becky Hyde, Chief Marketing Officer, Horizon Science Pty Ltd, Australia
- Dr Dianne Jackson-Matthews, Director of Regulatory Affairs, ERA Consulting, Australia
- Dr Jane Jacobs, Director, Office for Health and Medical Research , Queensland Health, Australia
- Dr Juan Juttner, Manager Gene Discovery, Grains Research and Development Corporation
- Anne-Maree Keane, Partner Transaction Advisory Services, Ernst & Young, Australia
- Professor Brendon Kearney, Chair - Health Policy Advisory Committee, Technology (HealthPACT) & EuroScan International Network
- Dr Andrew Kelly, Executive Director, BioPacific Ventures , New Zealand
- Dr Paul Kelly, General Partner, One Ventures, Australia
- Dr Robert Kilpatrick, CEO, Technology Vision Group, United States
- Andreas Knaack, Director Biomedical Instruments and Devices, Invetech, Australia
- Dr Mark Krstic, President, Australian Society of Viticulture and Oenology, Australia
- Professor Peter Langridge, Chief Executive Officer, ACPFG, Australia
- Dr Ron Laufer, Managing Director, MedImmune Ventures, United States
- Ian Lewis, Director, SAMIAN Underwriting, United Kingdom
- Peter Lewis, General Mananger - Business Development, Hydrix, Australia
- Dr Terry Longhurst, Manager Strategic Science, Livestock Production Innovation, Meat & Livestock Australia, Australia
- Dr George Lovrecz, Head of Fermentation Group, Material Science and Engineering, CSIRO , Australia
- Dr Verna MacErlane, Director of Commercial Operations International, SISTEMIC, Scotland
- Paul MacLeman, Chief Executive Officer, Genetic Technologies Limited, Australia
- Liddy McCall, Director, Yuuwa Capital, Australia
- Dr Kristy McCamley, Intellectual Property Manager & Patent Attorney Research, Biota Holdings Limited, Australia
- Rob McInnes, Partner, Intellectual Property and Technology, Dibbs Barker, Australia
- Matthew McNamara, Chief Investment Officer, IB Australian Bioscience Fund, Australia
- Dr Jurgen Michaelis, Chief Executive Officer, BioInnovation SA, Australia
- Professor Michael Miller AO, Chair, ATSE SA Division, Australia
- Dr Jo Mitchell, Assoc Director Research, Ethics and Public Health Training, New South Wales Health, Australia
- Lisa Nelson, Business Development Manager, Nucleus Network, Australia
- Dr Ian Nisbet, Founder & Partner, Afandin Pty Ltd, Australia
- Dr Sarah Norris, Co-Director, Health Technology Analysts, Australia
- Dr Anthony Filippis, Partner, Afandin Pty Ltd, Australia
- Kim O'Connell, Partner, Mallesons Stephen Jacques, Australia
- Dr Esra Ogru, Chief Executive Officer, Phosphagenics, Australia
- Dr Tim Oldham, Corporate Vice President and President, Asia Pacific, Hospira, Australia
- Eugene Ong, Lead Sales Manager, Ansarada, Australia
- Patricia Osidacz, Senior Sensory Scientist, The Australian Wine Research Institute, Australia
- Naomi Pearce, IP Director & Counsel, Hospira, Australia
- Dr Jenny Petering, Partner, FB Rice, Australia
- Dr Susan Pond, Dow Sustainability Program, United States Studies, Australia
- Dr Kishore Prayaga, Product Development Manager (ANZ), Pfizer Animal Health Asia Pacific, Australia
- Professor Sakkie Pretorius, Managing Director, The Australian Wine Research Institute, Australia
- Professor Stephen Prowse, CEO , CRC for Wound Management, Australia
- Michael Quinn, Managing Partner, Innovation Capital, Australia
- Professor Roger Reddel, Director, Children's Medical Research Institute, Australia
- Dr Alan Robertson, Chief Executive Officer, Pharmaxis, Australia
- Dr Klaus B. Schoepe, Senior Vice President Client Relations, Rentschler Biotechnologie Gmbh, Germany
- Brendan Shaw, Chief Executive, Medicines Australia, Australia
- Dr William Shen, Partner, venbio, United States
- Kym Short, Clinical Project Manager, AstraZeneca, Australia
- Professor Robert Short, Director of the Mawson Institue, University of SA, Australia
- Dr William Sietsema, Vice President Global Regulatory Consulting & Submissions, INC Research, United States
- Dr Richard Soll, Senior Vice President of Integrated Services, WuXi AppTec, China
- Dr German Spangenberg, DPI, Victorian Government, Australia
- Shane Storey, Senior Research Analyst, Wilson HTM, Australia
- Joe Sum, Vice President, Biotechnology Value Fund, United States
- Dr Anthony Sun, Principal, Aisling Capital , United States
- Dr Alex Szabo, Principal, Golden Gate Life Sciences Partners, Australia
- Professor Mark Tester, VP, Company Director & Co-Founder, BIOCONST Pty Limited
- Ian Thompson, Managing Director, Amgen Australia
- Dr Alexandra Tickle, Commercialisation Manager, Otago Innovation, New Zealand
- Dr Richard Treagus, Chief Executive Officer, Acrux, Australia
- Cameron Turner, Innovation and Commercial Development Manager, UniQuest, Australia
- Dr Meera Verma, Director Site Operations, Hospira, Australia
- Dr Stewart Washer, Investment Committee, IB Fund, Australia
- Karen West, Senior Director Clinical Operations Asia Pacific, INC Research
- Nicole Williamson, Senior Technology Manager - Sustainable Aviation Fuel, Boeing Research and Technology Australia
- Michael Wonder, Wonder Drug Consulting, Australia
- Dr Graeme Woodrow, Director, Health Technologies Strategy, CSIRO, Australia
- Nick Woolf, CFO VP Corporate Development Phylogica, Australia
- Dr Stella Xu, Regional Head, Greater China and Southeast Asia, Roche Partnering, China
* confirmed from September - subject to change
